Scientist, Preclinical Safety & Translational Sciences -Translational PK at Johnson & Johnson

San Diego, California, United States

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Biotechnology, HealthcareIndustries

Requirements

Bachelor's degree in Biomedical Science, Pharmaceutical Science or a relevant Life Sciences field (required); advanced degree (Master's) highly preferred
Minimum of 3+ years of relevant experience (or 2+ years with Master's degree)
Experience with designing, performing, and interpreting a broad range of in vitro ADME assays such as metabolic stability, DDI, CYP inhibition, CYP induction, plasma protein or tissue binding assays

Responsibilities

Independently designing, performing, and managing various in vitro screening and mechanistic ADME studies to address specific DMPK questions in drug discovery
Developing analytical methods using mass spectrometry (LC-MS/MS and HRMS) to separate and detect small molecules and other modalities
Analyzing and interpreting experimental data
Preparing and delivering scientific presentations and reports to communicate research results within and outside the TPPIT department
Maintaining current knowledge of relevant scientific literature and evaluating implications for internal projects
Maintaining laboratory equipment as well as clear, detailed, and up-to-date experimental records

Skills

ADME

Pharmacokinetics

Pharmacodynamics

In Vitro Screening

Toxicokinetics

Investigative Toxicology

PK/PD

Translational Sciences

Johnson & Johnson

Healthcare products in pharmaceuticals and devices.

About Johnson & Johnson

Johnson & Johnson operates in the healthcare sector with three main areas: pharmaceuticals, medical devices, and consumer health products. In the pharmaceuticals segment, the company develops prescription drugs for various medical conditions such as cancer and infectious diseases. The medical devices segment provides products used in surgeries and other medical procedures, while the consumer health segment offers over-the-counter products, including baby care and personal health items. Johnson & Johnson generates revenue through direct sales and partnerships, and it invests significantly in research and development to create new products that meet the needs of consumers and healthcare providers. The company stands out from competitors by emphasizing diversity, equity, and inclusion in its workplace, fostering an environment where employees can share their perspectives. Its goal is to improve patient outcomes and enhance the overall health and well-being of individuals globally.

New Brunswick, New JerseyHeadquarters

1886Year Founded

IPOCompany Stage

HealthcareIndustries

10,001+Employees

Risks

J&J faces a class action lawsuit in Australia over ineffective cold and flu medications.

Former J&J executives joining other firms could lead to increased competition.

Ongoing legal battles, like the lawsuit against Cigna, pose financial liabilities for J&J.

Differentiation

J&J operates in three segments: pharmaceuticals, medical devices, and consumer health.

The company invests heavily in R&D for innovative medical solutions and products.

J&J is committed to diversity, equity, and inclusion in its workplace culture.

Upsides

J&J's collaboration with Helsinki University Hospital focuses on value-based healthcare models.

The rise of personalized medicine offers J&J opportunities in targeted therapies.

Increased focus on digital health solutions presents expansion opportunities for J&J.

Land your dream remote job 3x faster with AI

Try Jobo Free